merck & co. inc.
(MRK:New York Consolidated)
Earnings & Estimates Summary - MERCK & CO. INC. (MRK)
2013 revenues at Merck & Co. Inc. totaled $44.0B USD, while annual earnings equaled $3.49 per share.
Quarterly Earnings & Estimates - MERCK & CO. INC. (MRK)
Merck & Co. Inc.'s Quarterly Earnings
Merck & Co. Inc. reported 2nd quarter 2014 earnings of $0.85 per share on 07/31/2014.
Annual Earnings & Estimates - MERCK & CO. INC. (MRK)
Merck & Co. Inc.'s Annual Earnings
Merck & Co. Inc. reported annual 2013 earnings of $3.49 per share on 02/7/2014.
Quarterly Revenues - MERCK & CO. INC. (MRK)
Merck & Co. Inc.'s Quarterly Revenues
Merck & Co. Inc. had 2nd quarter 2014 revenues of $10.9B USD. This bettered the $10.6B USD consensus of the 14 analysts covering the company. This was -0.7% below the prior year's 2nd quarter results.
Annual Revenues - MERCK & CO. INC. (MRK)
Merck & Co. Inc.'s Annual Revenues
Merck & Co. Inc. had revenues for the full year 2013 of $44.0B USD. This was -6.8% below the prior year's results.
|3M Co||$151.45 USD||+0.34|
|Amgen Inc||$171.47 USD||-1.27|
|Bayer AG||€135.63 EUR||+4.63|
|Gilead Sciences Inc||$115.71 USD||+2.64|
|GlaxoSmithKline PLC||1,375 GBp||+46.00|
|View Industry Companies|